Identification of Metabolites of Carcinogens by ¹³C NMR Spectroscopy

References

• Miller E. C., Miller J. A. Searches for ultimate chemical carcinogens and their reactions with cellular macromolecules. Cancer 1981; 47: 2327–2345
   PubMed Web of Science ®Google Scholar
• Fennell T. R., Kedderis G. L., Sumner S. C. J. Urinary metabolites of (l,2,3-l3C]acrylonitrile in rats and mice detected by l3C nuclear magnetic resonance spectroscopy. Chem. Res. Toxicol. 1991; 4: 678–687
   PubMed Web of Science ®Google Scholar
• Sumner S. C. J., MacNeela J. P., Fennell T. R. Characterization and quantitation of urinary metabolites of [1,2,3-13C]acrylamide in rats and mice using 13C nuclear magnetic resonance spectroscopy. Chem. Res. Toxicol. 1992; 5: 81–89
   PubMed Web of Science ®Google Scholar
• Hunter B. K., Nicholls K. M., Sanders J. K. M. Formaldehyde metabolism by Escherichia coli. In vivo carbon, deuterium, and two-dimensional NMR observations of multiple detoxifying pathyways. Biochemistry 1984; 23: 508–514
   PubMed Web of Science ®Google Scholar
• Dohn D. R., Graziano M. J., Casida J. E. Metabolites of [3-l3C]l,2- dibromo-3-chloropropane in male rats studied by l3C and 'H-l3C correlated two-dimensional NMR spectroscopy. Biochem. Pharmacol. 1988; 37: 3485–3495
   PubMed Web of Science ®Google Scholar
• Tecle B., Casida J. E. Enzymatic defluorination and metabolism of fluoroacetate, fluoroacetamide, f luoroethanol, and (–)-f luorocitrate in rats and mice examined by l9F and l3C NMR. Chem. Res. Toxicol. 1989; 2: 429–435
   PubMed Web of Science ®Google Scholar
• Meese C. O., Fischer P. Tracing the human metabolism of stable isotope-labelled drugs by ex vivo NMR spectroscopy. A revision of S-carboxymethyl-L-cysteine biotransformation. Z. Naturforsch. 1990; 45c: 1171–1175
   Google Scholar
• Maltoni C., Ciliberti A., Cotti G., Perino G. Experimental Research on Acrylonitrile Carcinogenesis. Princeton Scientific Publishing, Princeton 1987
   Google Scholar
• Ahmed A. E., Patel K. Acrylonitrile: In vivo metabolism in rats and mice. Drug Metab. Dispos. 1981; 9: 219–222
   PubMed Web of Science ®Google Scholar
• Miller M. S., Spencer P. S. The mechanisms of acrylamide axon-opathy. Annu. Rev. Pharmacol. Toxicol. 1985; 25: 643–666
   PubMed Web of Science ®Google Scholar
• Dearfield K. L., Abernathy C. O., Ottley M. S., Brantner J. H., Hayes P. F. Acrylamide, its metabolism, developmental and reproductive effects, genotoxicity, and carcinogenicity. Mum. Res. 1988; 195: 45–77
   PubMed Web of Science ®Google Scholar
• Miller M. J., Carter D. E., Sipes I. G. Pharmacokinetics of acrylamide in Fischer 344 rats. Toxicol. Appl. Pharmacol. 1982; 63: 36–64
   PubMed Web of Science ®Google Scholar
• Calleman C. J., Bergmark E., Costa L. G. Acrylamide is metabolized to glycidamide in the rat: Evidence from hemoglobin adduct formation. Chem. Res. Toxicol. 1990; 3: 406–412
   PubMed Web of Science ®Google Scholar
• Guengerich F P., Geiger L. E., Hogy L. L., Wright R L. In vitro metabolism of acrylonitrile to cyanoethylene oxide, reaction with glutathione, and irreversible binding to proteins and nucleic acids. Cancer Res. 1981; 41: 4925–4933
   PubMed Web of Science ®Google Scholar
• Langvardt R W., Putzig C. L., Braun W. H., Young J. D. Identification of the major urinary metabolites of acrylonitrile in the rat. J. Toxicol. Environ. Health 1980; 6: 273–282
   PubMed Web of Science ®Google Scholar
• Linhart I., Smejkal J., Novak J. N-Acetyl-5-(1 -cyano-2-hydroxyethyl)-L-cysteine, a new urinary metabolite of acrylonitrile and oxiranecarbonitrile. Arch. Toxicol. 1988; 61: 484–488
   PubMed Web of Science ®Google Scholar
• Müller G., Verkoyen C., Soton N., Norpoth K. Urinary excretion of acrylonitrile and its metabolites in rats. Arch. Toxicol. 1987; 60: 464–466
   PubMed Web of Science ®Google Scholar
• van Bladeren P. J., Delbressine L. P. C., Hoogerterp J. J., Beaumont A. H.G. M., Breimer D. D., Seutter-Berlage F., van der Gen A. Formation of mercapturic acids from acrylonitrile, cro-tononitrile, and cinnamonitrile by direct conjugation and via an intermediate oxidation process. Drug Metab. Dispos. 1981; 9: 246–249
   PubMed Web of Science ®Google Scholar
• Gut I., Nerudova J., Kopecky J., Holecek V. Acrylonitrile biotransformation in rats, mice, and Chinese hamsters as influenced by the route of administration and by phenobarbital, SKF 525-A, cysteine, dimercaprol, or thiosulfate. Arch. Toxicol. 1975; 33: 151–161
   PubMed Web of Science ®Google Scholar
• Rouisse L., Chakrabarti S., Tuchweber B. Acute nephrotoxic potential of acrylonitrile in Fischer-344 rats. Res. Commun. Chem. Pathol. Pharmacol. 1986; 53: 347–360
   PubMedGoogle Scholar
• Vodicka P., Gut I., Frantik E. Effects of inhaled acrylic acid derivatives in rats. Toxicology 1990; 65: 209–221
   PubMed Web of Science ®Google Scholar
• Bax A., Freeman R., Frenkiel T. A. An NMR technique for tracing out the carbon skeleton of an organic molecule. J. Am. Chem. Soc 1981; 103: 2102–2104
   Web of Science ®Google Scholar
• Müller L., Kumar A., Ernst R. R. Two-dimensional carbon-13 NMR spectroscopy. J. Chem. Phys. 1975; 63: 5490–5491
   Web of Science ®Google Scholar
• Roberts A. E., Kedderis G. L., Turner M. J., Rickert D. E., Swenberg J. A. Species comparison of acrylonitrile epoxidation by microsomes from mice, rats, and humans: Relationship to epoxide concentrations in mouse and rat blood. Carcinogenesis 1991; 12: 401–404
   PubMed Web of Science ®Google Scholar
• Guengerich F. P., Kim D. -H., Iwasaki M. Role of Human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects. Chem. Res. Toxicol. 1991; 4: 168–179
   PubMed Web of Science ®Google Scholar
• Calleman C. J., Stern L. G., Bergmark E., Costa L. G. Linear versus nonlinear models for hemoglobin adduct formation by acryla-mide and its metabolite glycidamide: Implications for risk estimation. Cancer Epidem. Biomark. Prevent. 1992; 1: 361–368
   PubMed Web of Science ®Google Scholar
• Costa L. G., Deng H., Gregotti C., Manzo L., Faustman E. M., Bergmark E., Calleman C. J. Comparative studies on the neuro- and reproductive toxicity of acrylamide and its metabolite glycidamide in the rat. Neurotoxicology 1992; 13: 219–224
   PubMed Web of Science ®Google Scholar
• Csanady G., Guengerich F. P., Bond J. A. Comparison of the biotransformation of 1,3-butadiene and its metabolite, butadiene mo-noepoxide, by hepatic and pulmonary tissues from humans, rats and mice. Carcinogenesis 1992; 13: 1143–1153
   PubMed Web of Science ®Google Scholar
• Laib R. J., Tucholski M., Filser J. G., Csanady G. Pharmacokinetic interaction between 1,3-butadiene and styrene in Sprague-Dawley rats. Arch. Toxicol. 1992; 66: 310–314
   PubMed Web of Science ®Google Scholar
• Normandeau J., Chackrabarti S., Brodeur J. Influence of simultaneous exposure to acrylonitrile and styrene on the toxicity and metabolism of styrene in rats. Toxicol. Appl. Pharmacol. 1984; 75: 346–349
   PubMed Web of Science ®Google Scholar